老年肝细胞癌患者的治疗现状

摘要

随着全球老龄化加剧,老年人肝细胞癌(HCC)的发病率越来越高,使其成为一个全球性的健康问题.通过查阅大量相关文献分析了老年HCC患者的临床特点,综述了其治疗方法和疗效方面的现状.其中对疗效的评述主要是通过对世界上多个国家和地区的老年与非老年HCC患者治疗效果的对比体现的.指出HCC老年患者具有自身的临床特点,并且由于HCC老年患者常常合并其他疾病,如糖尿病、肾衰竭、肺和心血管疾病等,使得其治疗的风险增加,但是其疗效是肯定的.随着研究的深入,各种治疗方法的改进,老年人HCC的治疗效果也将提高,因此在临床工作中应采用积极的态度和策略治疗HCC老年患者.%With the global aging, the incidence rate of HCC in the elderly population is gradually increasing , and thus it has become a global health issue.With reference to relevant literature, this article analyzes the clinical features of elderly HCC patients and reviews the current status of therapies and clinical outcomes .The review of clinical outcomes is mainly based on the comparison of therapeutic outcome between elderly and non -elderly HCC patients in many countries and regions in the world .This article points out that elderly HCC patients have their own clinical features, and since elderly HCC patients often have other diseases , such as diabetes, renal failure, and lung and cardiovascular diseases, there is an increase in the risk of treatment, but they often have positive treatment outcomes .With the deepening of research and the improvement of various treatment methods , the therapeutic outcome of elderly HCC patients will also be improved .Therefore,positive attitude and strategies should be adopted in the clinical treatment of elderly HCC patients .